ArticleNeurosurgical focus2025
Long-term outcomes after microvascular decompression for glossopharyngeal neuralgia.
Article in Neurosurgical focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveLong-term data on outcomes following microvascular decompression (MVD) without neurectomy for glossopharyngeal neuralgia (GPN), specifically focusing on pain location, are sparse. The aim of this study was to investigate the long-term efficacy and safety of MVD without neurectomy for GPN with particular emphasis on redo MVD and pain location.
methodsConsecutive patients who underwent MVD for classical GPN performed by the senior author from 2013 to 2021 were included in this retrospective cohort study. Medical records were reviewed, and clinical and telemedicine follow-up were analyzed to assess outcomes.
resultsAmong 29 patients (18 male, median age at surgery 65.0 years) included in the analysis, 38% had throat pain radiating to the ear and 35% had throat pain only. Eleven patients (38%) had previously undergone other unsuccessful procedures. After MVD, 83% of patients were immediately pain free and 10% experienced partial pain relief. The mean follow-up duration was 65.3 months. At the final follow-up, 86% of patients were completely pain free and 11% had partial pain relief. Three patients each (10% and 11%) experienced immediate and long-term complications, respectively. Redo MVD completely relieved pain in 3 of 4 patients.
conclusionsThese findings support the use of MVD without neurectomy in patients with classical GPN, including redo MVD in patients with persistent neurovascular compression. The direction of symptom radiation was not associated with pain outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.